TD Cowen Lowers agilon health (NYSE:AGL) Price Target to $2.00

agilon health (NYSE:AGLFree Report) had its price target trimmed by TD Cowen from $6.00 to $2.00 in a report released on Monday,Benzinga reports. The brokerage currently has a hold rating on the stock.

Several other brokerages have also recently commented on AGL. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a report on Friday. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. JMP Securities cut agilon health from an “outperform” rating to a “market perform” rating in a report on Monday. Barclays cut their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday. Finally, Evercore ISI cut their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Three equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $7.34.

Get Our Latest Analysis on agilon health

agilon health Stock Performance

agilon health stock opened at $2.16 on Monday. The business has a 50 day moving average of $3.22 and a 200-day moving average of $4.95. agilon health has a 1 year low of $1.80 and a 1 year high of $13.76. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The company has a market capitalization of $888.80 million, a P/E ratio of -2.30 and a beta of 0.60.

agilon health (NYSE:AGLGet Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 46.06%. The firm had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same period in the prior year, the company earned ($0.06) EPS. On average, equities research analysts predict that agilon health will post -0.32 earnings per share for the current year.

Insider Activity

In other agilon health news, CEO Steven Sell purchased 20,000 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. The trade was a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Large investors have recently modified their holdings of the business. J.Safra Asset Management Corp boosted its position in shares of agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after acquiring an additional 3,625 shares during the last quarter. CWM LLC boosted its position in shares of agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after acquiring an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC bought a new stake in shares of agilon health during the 2nd quarter valued at about $60,000. Bleakley Financial Group LLC purchased a new position in shares of agilon health during the 1st quarter valued at about $65,000. Finally, Allspring Global Investments Holdings LLC raised its holdings in shares of agilon health by 17,790.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after buying an additional 10,674 shares in the last quarter.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.